The Soriot company said the first 300 million cans will be sold “at cost”.
Read for 4 minutes
The representatives of Astra Zeneca and ModernPharmaceutical and biotechnology companies working on projects to develop a vaccine against the SARSCoV2 virus announced on Tuesday, July 21, before the Subcommittee on Monitoring and Investigation of the House of Representatives Energy and Trade Commission. United, the possibility that Covid-19 vaccination before the end of the year.
According to reports CNNMene Pangalos, executive vice president of research and development for biopharmaceuticals at Astra Zeneca, warned in a hearing before the US Congress that the vaccine “will be available everywhere if clinical trials (already in phase three) deliver the expected results right now September “.
Dr. For his part, Stephen Hoge, President of Moderna, said: “We hope that we will have to submit data to the Food and Drug Administration (FDA) in the fall or late this year so that they can make a decision on vaccine approval. “”
It is important to note that the first clinical studies conducted by Astra Zeneca have shown that they produce a good immune response and are safe for patients. In the current third test phase, the pharmaceutical company has to work with a larger number of participants. Once the effectiveness of the vaccine has been demonstrated, marketing can begin.
To date, laboratories and researchers around the world have been developing around 200 projects to find a COVID-19 vaccine as quickly as possible. Of these, only 23 were tested on humans.
“We work in accordance with the regulatory authorities and exchange daily data so that the assessment can be carried out quickly. We also carry out clinical trials and save time,” added Pascal Soriot, CEO of Astra Zeneca.
Likewise, Soriot He explained that the first 300 million cans will be sold “at cost” to all countries in the world, which means that they will not make any additional profit from their sales. The cost for each unit is around 2.5 euros, i.e. 65 Mexican pesos.
Soriot said the first 300 million cans will be sold “at cost” / Image: Depositphotos.com
Johnson Johnson It has also joined the cause, which is why its representatives pointed out that its first cans are also sold at cost price in a world emergency.
On the other hand, American companies like it Moderna, Pfizer and Merck You mentioned that you will not sell your vaccines at cost price. For this reason, John Young, Pfizer’s Business Director said, “During the pandemic, we will evaluate our potential vaccine taking into account the current global health emergency.”
“We have a clear line of sight and a clear clinical path to deliver up to 100 million doses of vaccine on a commercial scale in 2020 and up to 1.3 billion doses of our vaccine in 2021,” he added.
To date, there are more than 14 million cases and more than 617,000 coronavirus deaths worldwide. The most affected country is the United States, with more than 142,000 deaths.